Cancer stem cells and therapeutic targets: an emerging field for cancer treatment
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer stem cells and therapeutic targets: an emerging field for cancer treatment
Authors
Keywords
Cancer stem cells, Drug resistance, CSC markers, Therapy targets
Journal
Drug Delivery and Translational Research
Volume 3, Issue 2, Pages 113-120
Publisher
Springer Nature
Online
2012-08-16
DOI
10.1007/s13346-012-0095-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Editorial [ Hot Topic:Recent Concepts on Cancer- and Metastasis-Initiating Cells and Their Therapeutic Implications in the Development of Novel Effective Cancer Therapies(Guest Editors: M. Mimeault and S.K. Batra) ]
- (2012) M. Mimeault et al. Anti-Cancer Agents in Medicinal Chemistry
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- EMT and Dissemination Precede Pancreatic Tumor Formation
- (2012) Andrew D. Rhim et al. CELL
- Sonic hedgehog maintains survival and growth of chronic myeloid leukemia progenitor cells through β-catenin signaling
- (2012) Wenxia Su et al. EXPERIMENTAL HEMATOLOGY
- Therapeutics formulated to target cancer stem cells: Is it in our future?
- (2011) Stephanie Clayton et al. Cancer Cell International
- Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
- (2011) Peter Friedl et al. CELL
- Notch signaling in mammalian hematopoietic stem cells
- (2011) K V Pajcini et al. LEUKEMIA
- Epithelial-Mesenchymal Transition in tumor microenvironment
- (2011) Yingying Jing et al. Cell and Bioscience
- Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: Latest advances towards an integrated approach
- (2010) Laura Vera-Ramirez et al. CANCER TREATMENT REVIEWS
- Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation
- (2010) Rita U. Lukacs et al. Cell Stem Cell
- A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
- (2010) Roberta Pang et al. Cell Stem Cell
- Targeting Hedgehog -- a Cancer Stem Cell Pathway
- (2010) A. A. Merchant et al. CLINICAL CANCER RESEARCH
- The Difficulty of Targeting Cancer Stem Cell Niches
- (2010) M. A. LaBarge CLINICAL CANCER RESEARCH
- Severe polyposis in Apc1322Tmice is associated with submaximal Wnt signalling and increased expression of the stem cell markerLgr5
- (2010) Annabelle Lewis et al. GUT
- Mesenchymal Stem Cells Modified with a Single-Chain Antibody against EGFRvIII Successfully Inhibit the Growth of Human Xenograft Malignant Glioma
- (2010) Irina V. Balyasnikova et al. PLoS One
- Therapeutic strategies by modulating oxygen stress in cancer and inflammation
- (2009) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Breast cancer stem cells: tools and models to rely on
- (2009) Emmanuelle Charafe-Jauffret et al. BMC CANCER
- A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen
- (2009) Paul Ruff et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hedgehog Signaling Is Dispensable for Adult Murine Hematopoietic Stem Cell Function and Hematopoiesis
- (2009) Inga Hofmann et al. Cell Stem Cell
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
- (2009) Anne-Marie Bleau et al. Cell Stem Cell
- Targeted Elimination of Leukemia Stem Cells; a New Therapeutic Approach in Hemato-Oncology
- (2009) B. Cate et al. CURRENT DRUG TARGETS
- Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia
- (2009) Alberto M Martelli et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Bone marrow mesenchymal stem cells from leukemia patients inhibit growth and apoptosis in serum-deprived K562 cells
- (2009) Zhaohui Wei et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability
- (2009) B ten Cate et al. LEUKEMIA
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
- (2009) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transport proteins of the ABC family and multidrug resistance of tumor cells
- (2008) A. A. Stavrovskaya et al. BIOCHEMISTRY-MOSCOW
- Deletion of the WNT Target and Cancer Stem Cell Marker CD44 in Apc(Min/+) Mice Attenuates Intestinal Tumorigenesis
- (2008) J. Zeilstra et al. CANCER RESEARCH
- Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal
- (2008) J. Godlewski et al. CANCER RESEARCH
- Current View: Intestinal Stem Cells and Signaling
- (2008) David H. Scoville et al. GASTROENTEROLOGY
- Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer
- (2008) Catherine Lhommé et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic Cancer Stem Cells
- (2008) Cheong J. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
- Ovarian cancer: emerging concept on cancer stem cells
- (2008) Moorthy P Ponnusamy et al. Journal of Ovarian Research
- Expression of CD133-1 and CD133-2 in ovarian cancer
- (2007) G. FERRANDINA et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More